Project Grant R21EB037156
- This Project Grant award, valued at $595,353 and issued on February 1, 2025 by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), supports the development of ultrasensitive ion-selective optodes for self-testing of blood electrolytes. The goal is to create a novel colorimetric sensor capable of detecting electrolyte levels in just a few microliters of whole blood, revolutionizing the self-monitoring of chronic conditions like hypoparathyroidism and congestive heart failure....
- This $426,938 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health aims to develop self-calibrating ion-selective electrodes for at-home monitoring of blood electrolytes. The 2-year grant to Virginia Commonwealth University (VCU) will focus on designing portable, transportable, and mass-producible Ca2+ and K+ sensors that can provide accurate and...
- This $360,320 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) aims to develop and test the first continuous electrochemical sensors for monitoring large protein and peptide analytes, such as insulin and cardiac markers. The project, titled "Aptamer Tagging with Redox Quenchers: A Critical Breakthrough in the Sensitivity of...
- This $400,000 Project Grant from the National Science Foundation's Division of Electrical, Communications and Cyber Systems, under the Engineering (47.041) federal grant program, will fund research at Georgia Tech Research Corporation to advance implantable bioelectronics for continuous monitoring of vascular health. Specifically, the grant will support understanding of printing soft microstructures for enhanced sensor sensitivity, study of passive wireless sensing principles and 3D...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $366,006 Project Grant (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health) to the Georgia Tech Research Corporation to develop flexible piezo film intravascular ultrasound (IVUS) arrays on guidewires and catheters. The goal is to integrate IVUS imaging capability onto standard guidewires and catheters used in over 1 million percutaneous coronary and peripheral...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $413,067 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Colorado State University to develop a new class of electrochemical biosensors that use engineered binding proteins. The goal is to simplify fabrication and improve performance of electrochemical sensors, which have potential for inexpensive, sensitive, and quantitative...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $359,995 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to Clemson University. The funding supports the development and validation of a novel X-ray visualized immunosensor (X-VIS) that can be attached to implanted medical devices to detect and monitor local infection biomarkers. The project aims to fabricate a...
- This federal Project Grant award from the National Center for Advancing Translational Sciences (NCATS), with CFDA Number 93.350, supports the development of a novel method for quantitative flow assessment within the treated artery during catheter embolization procedures. The $144,345 award will fund research to integrate electrochemical impedance spectroscopy (EIS) sensors into catheters for real-time monitoring of embolization, which can provide a more accurate evaluation of the embolization...
- The National Science Foundation (NSF) awarded a three-year, $449,999 Project Grant under their Engineering program (CFDA 47.041) to the University of Cincinnati to develop an implantable biosensor platform that can continuously monitor various biomarkers in the body for over a year. The project aims to create a new class of long-lasting aptamer-based sensors protected by robust porous oxide coatings, which would enable the first practical implantable monitoring system for managing chronic...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $306,463 Project Grant under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program to Dogpatch Medical LLC, effective September 1, 2025 through August 31, 2026. The grant funding supports the development of PASSIVECATH, an innovative microcatheter device designed for enhanced visibility and targeted drug delivery to the central nervous system...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286) provides $418,284 to the Georgia TECH Research Corp to evaluate the performance of a new ion sensor-integrated central venous catheter (CVC) and an automated system for real-time correction of electrolyte imbalances. The research project aims to replace traditional blood draw-based testing by enabling continuous, non-invasive monitoring of blood electrolytes through the CVC sensor technology. This would allow for early detection and automated treatment of metabolic imbalances in critically ill patients, reducing the need for frequent blood draws and associated risks. The two-year project period runs from Sep 1, 2025 to Aug 31, 2027 and will involve in vitro and in vivo testing to validate the accuracy, sensitivity, and stability of the CVC sensor system and its ability to autonomously correct electrolyte imbalances.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $418.3k | 8/6/25 |